glp-1 c elegans Notch—LAG-1 CSL control of the germline stem cell fate is mediated by transcriptional targets lst-1 and sygl-1 Loss of the distal-proximal GLP-1/Notch

are administered orally once daily, although the specific dosing parameters for each individual agent varies, as summarized in Table 2

Scientists investigate their molecular structures, biological effects, and formulation challenges to refine experimental models of diabetes and obesity

These results suggest there is no excess cardiovascular risk with tirzepatide and are consistent with the improvements of numerous surrogate markers of cardiovascular health, including weight reduction, glycemic control with less hypoglycemia, blood pressure reduction, and improvements in the lipid profile

Even more ambitious approaches are on the horizon

Regular monitoring is essential, as temporary plateaus or changes might occur

In our latest episode of MTP, Dr